TELEPHONE: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com
Report Overview ‘Smoking Addiction - Pipeline Review, H1 2016’, provides an overview of the Smoking Addiction pipeline landscape. The report provides comprehensive information on the therapeutics under development for Smoking Addiction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Read More At: http://www.researchbeam.com/smoking-addiction-pipeline-review-h1-2016-market
Report Overview Scope • The report provides a snapshot of the global therapeutic landscape of Smoking Addiction • The report reviews pipeline therapeutics for Smoking Addiction by companies and universities/research institutes based on information derived from company and industryspecific sources • The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages • The report summarizes all the dormant and discontinued pipeline projects • The report reviews latest news related to pipeline therapeutics for Smoking Addiction
Reasons to buy • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies • Identify emerging players and create effective counter-strategies to gain competitive advantage • Identify important and diverse types of therapeutics under development for Smoking Addiction • Identify potential new clients or partners in the target demographic • Develop strategic initiatives by understanding the focus areas of leading companies
Read More At: http://www.researchbeam.com/smoking-addiction-pipeline-review-h1-2016-market
Table of Content List Of Figures Number of Products under Development for Smoking Addiction, H1 2016 10 Number of Products under Development for Smoking Addiction - Comparative Analysis, H1 2016 11 Number of Products under Development by Companies, H1 2016 12 Number of Products under Investigation by Universities/Institutes, H1 2016 14 Comparative Analysis by Clinical Stage Development, H1 2016 15 Comparative Analysis by Early Stage Products, H1 2016 16 Assessment by Monotherapy Products, H1 2016 35 Number of Products by Top 10 Targets, H1 2016 37 Number of Products by Stage and Top 10 Targets, H1 2016 37 Number of Products by Top 10 Mechanism of Actions, H1 2016 39 Number of Products by Stage and Top 10 Mechanism of Actions, H1 2016 39 Number of Products by Routes of Administration, H1 2016 41 Number of Products by Stage and Routes of Administration, H1 2016 41 Number of Products by Molecule Types, H1 2016 43 Number of Products by Stage and Molecule Types, H1 2016 43 Enquire More At: http://www.researchbeam.com/smoking-addiction-pipeline-review-h1-2016market/enquire-about-report
FOR MORE DETAILS Visit us at : http://www.researchbeam.com/smoking-addiction-pipeline-review-h1-2016market
Stay With Us:
TELEPHONE: +1 (800) 910-6452 DIRECT: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com
5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States